<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03525912</url>
  </required_header>
  <id_info>
    <org_study_id>UdeA1002</org_study_id>
    <nct_id>NCT03525912</nct_id>
  </id_info>
  <brief_title>Neuropsychiatric and Cardiovascular Side Effects in Ketamine Analgesic Infusions</brief_title>
  <official_title>Neuropsychiatric and Cardiovascular Side Effects in Ketamine Analgesic Infusions: a Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad de Antioquia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad de Antioquia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of neuropsychiatric and cardiovascular side effects of low dose ketamine analgesic
      infusion for postoperative pain
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Postoperative pain is a world wide problem related with surgery. Multimodal analgesia may
      include ketamine, aimed to decrease opioid adverse effects in postoperative analgesia for
      major surgery, and risk of chronic postsurgical pain. Ketamine has shown efficacy as adjuvant
      in multimodal analgesia, however, neuropsychiatric and cardiovascular effects of ketamine at
      low doses in continue postoperative infusion are less known. This type of adverse effects may
      compromise appropriated recovery.

      Objective

      to determine frequency of delirium, agitation, sedation, hallucinations, bad dreams and
      cardiovascular changes associated with ketamine analgesic infusion treatment for
      postoperative pain.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2017</start_date>
  <completion_date type="Anticipated">August 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>single group assignment interventional</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Delirium</measure>
    <time_frame>2 days</time_frame>
    <description>Presence or absence of delirium at 24 and 48 hours postoperatively over the past 2 days of exposure to ketamine infusion, using the Confusion Assessment Method (CAM), a clinical based assessment tool for identifying delirium. Consist of 4 criteria ( timing of symptoms, attention, thinking, consciousness). Considered to be positive for delirium if both features 1 and 2 are present, with at least one of features 3 or 4.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Agitation</measure>
    <time_frame>24 and 48 hours postoperatively</time_frame>
    <description>Richmond Agitation- Sedation Scale (RASS) score is a 10 point scale with discrete criteria, with four levels of agitation (+1 to +4), one level for calm and alert state (0), and 5 levels of sedation (−1 to −5)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedation</measure>
    <time_frame>24 and 48 hours postoperatively</time_frame>
    <description>Clinician based Richmond Agitation- Sedation Scale (RASS) at 24 and 48 hours. RASS is a 10 point scale with discrete criteria, with four levels of agitation (+1 to +4), one level for calm and alert state (0), and 5 levels of sedation (−1 to −5)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Hallucinations</measure>
    <time_frame>24 and 48 hours postoperatively</time_frame>
    <description>Presence or absence of hallucinations</description>
  </other_outcome>
  <other_outcome>
    <measure>Bad Dreams</measure>
    <time_frame>24 and 48 hours postoperatively</time_frame>
    <description>Presence or absence of bad dreams</description>
  </other_outcome>
  <other_outcome>
    <measure>Hypertension</measure>
    <time_frame>0, 24 and 48 hours postoperatively</time_frame>
    <description>Hypertension is defined as a systolic blood pressure (SBP) of 140 mm Hg or more</description>
  </other_outcome>
  <other_outcome>
    <measure>Tachycardia</measure>
    <time_frame>0, 24 and 48 hours postoperatively</time_frame>
    <description>a heart rate of more than 100 beats per minute (BPM)</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Pain, Postoperative</condition>
  <condition>Ketamine Adverse Reaction</condition>
  <arm_group>
    <arm_group_label>Ketamine infusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>postoperative pain in adult population after abdominal, thoracic and orthopedic surgery that received adjuvant analgesia with ketamine 0.1mg/kg/h during 24 to 48 hours in postoperative period.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine</intervention_name>
    <description>continuous infusion of low dose ketamine for postoperative pain</description>
    <arm_group_label>Ketamine infusion</arm_group_label>
    <other_name>analgesic ketamine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - patient scheduled for abdominal, thoracic or orthopedic surgery

        Exclusion Criteria:

        cognitive disfunction psychiatric illness cardiovascular disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adriana M Cadavid, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Anesthesiology professor</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Adriana M Cadavid, MD</last_name>
    <phone>57-3104587978</phone>
    <email>adriana.cadavid@udea.edu.co</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gloria Valencia</last_name>
    <phone>57-4-2195194</phone>
    <phone_ext>5194</phone_ext>
    <email>asisinvestigacion@udea.edu.co</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>hospital universitario San Vicente Fundacion</name>
      <address>
        <city>Medellin</city>
        <state>Antioquia</state>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adriana M Cadavid, MD</last_name>
      <phone>573104587978</phone>
      <email>adriana.cadavid@udea.edu.co</email>
    </contact>
    <contact_backup>
      <last_name>Andrea Rodriguez, Nurse</last_name>
      <phone>5744441333</phone>
      <phone_ext>3604</phone_ext>
      <email>acrp89@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Colombia</country>
  </location_countries>
  <reference>
    <citation>Gorlin AW, Rosenfeld DM, Ramakrishna H. Intravenous sub-anesthetic ketamine for perioperative analgesia. J Anaesthesiol Clin Pharmacol. 2016 Apr-Jun;32(2):160-7. doi: 10.4103/0970-9185.182085. Review.</citation>
    <PMID>27275042</PMID>
  </reference>
  <reference>
    <citation>Laskowski K, Stirling A, McKay WP, Lim HJ. A systematic review of intravenous ketamine for postoperative analgesia. Can J Anaesth. 2011 Oct;58(10):911-23. doi: 10.1007/s12630-011-9560-0. Epub 2011 Jul 20. Review.</citation>
    <PMID>21773855</PMID>
  </reference>
  <reference>
    <citation>Li L, Vlisides PE. Ketamine: 50 Years of Modulating the Mind. Front Hum Neurosci. 2016 Nov 29;10:612. eCollection 2016. Review.</citation>
    <PMID>27965560</PMID>
  </reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 21, 2018</study_first_submitted>
  <study_first_submitted_qc>May 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 16, 2018</study_first_posted>
  <last_update_submitted>May 14, 2018</last_update_submitted>
  <last_update_submitted_qc>May 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad de Antioquia</investigator_affiliation>
    <investigator_full_name>Adriana Margarita Cadavid</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketamine</mesh_term>
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

